TI
1 insider bought shares over the last 90 days, the latest by 전재욱, filed 22 Sept 2026.
TegoScience Inc.: what insiders have been doing
TegoScience Inc. has a thin disclosure history in our data (latest filing: 22 September 2026). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySale전재욱1 buy
Financial data
as of FY 2025FY ended December 2025 · cache
₩6,820
Analyst consensus
Income statement
Revenue₩5.9B
Gross profit₩4B68% margin
EBITDA-₩6.3B-106% margin
Net income-₩7B-118.0% margin
Balance sheet & cash
Market cap₩54.6B
Total debt₩16.2B
Free Cash Flow-₩3.6B
Last declaration on 22 September 2026
Declarations5 total
- 162,177 sharesShareKRXDART:20260922000093Canonical exit: 21 Dec 2026 (T+90)
- Other0DART
- Other0DART
- ●Executives0DART
- ●Executives0DART
5 of 5 declarations
About TegoScience Inc.
Tego Science is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for the medical sector.
